ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Pittsburgh, PA, USA:

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic pancreatic...

Enrolling
Metastatic Pancreatic Cancer
Drug: Azeliragon

Phase 1, Phase 2

Cantex Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 5 other locations

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Pittsburgh, Pennsylvania, United States and 27 other locations

and clinical activity of AB680 in combination with zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Active, not recruiting
Advanced Pancreatic Cancer
Drug: Zimberelimab
Drug: Gemcitabine

Phase 1

Arcus Biosciences
Arcus Biosciences

Pittsburgh, Pennsylvania, United States and 17 other locations

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: RenovoCath
Drug: nab-paclitaxel

Phase 3

RenovoRx

Pittsburgh, Pennsylvania, United States and 41 other locations

and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

Phase 2

Actuate Therapeutics

Pittsburgh, Pennsylvania, United States and 65 other locations

administered orally as monotherapy in patients with advanced solid tumors with gene alterations in the RAS- MAPK pathway for whom there are ...

Enrolling
Solid Tumor, Adult
Pancreatic Cancer
Drug: IK-595

Phase 1

Ikena Oncology

Pittsburg, Pennsylvania, United States and 14 other locations

of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic...

Active, not recruiting
Advanced Cancer
Gastric Cancer
Drug: mFOLFOX6
Drug: Gemcitabine

Phase 1, Phase 2

Transcenta

Pittsburgh, Pennsylvania, United States and 17 other locations

This is a study of the combination of 9 ING-41 (elraglusib) and retifanlimab plus mFOLFIRINOX in patients with pancreatic cancer wi...

Not yet enrolling
Pancreatic Adenocarcinoma
Drug: Chemotherapy
Drug: Retifanlimab

Phase 1

Anwaar Saeed

Pittsburgh, Pennsylvania, United States

This is a first in human (FIH) 2-part study using ACTM-838 in patients with advanced solid tumors resistant to standard of care treatment. P...

Enrolling
Solid Tumor
Drug: ACTM-838

Phase 1

Actym Therapeutics

Pittsburgh, Pennsylvania, United States and 4 other locations

, metastatic castration-resistant prostate cancer (mCRPC), melanoma, pancreatic cancer, hepatocellular carcinoma (HCC), ov...

Active, not recruiting
Epithelial Ovarian Cancer
Advanced Solid Tumor
Biological: lorigerlimab
Biological: vobramitamab duocarmazine

Phase 1

MacroGenics
MacroGenics

Pittsburgh, Pennsylvania, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems